Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Thromboembolism 1Spinal Cord Neoplasms 1Respiratory Insufficiency 1Pneumonia 1Osteosarcoma 1Myocardial Infarction 1Lung Neoplasms 1Bone Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Acute Coronary Syndrome 1

Interventions

Temozolomide 10Radiotherapy 5Carboplatin 5Vincristine 4Radiosurgery 4Surveys and Questionnaires 3Magnetic Resonance Imaging 3Etoposide 3Bevacizumab 3etoposide phosphate 2Vorinostat 2Magnetic Resonance Spectroscopy 2Lomustine 2Irinotecan 2Immunoglobulin G 2Ifosfamide 2Fluorodeoxyglucose F18 2Disulfides 2Cisplatin 2veliparib 1tozuleristide 1romidepsin 1perillyl alcohol 1pembrolizumab 1olutasidenib 1lonafarnib 1ispinesib 1emvododstat 1cediranib 1abemaciclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinal Cord Neoplasms × Fluoridation × Clear all
NCT05493228 2022-08-09

Dexmedetomidine Infusion on Intraoperative Propofol,Fentanyl Requirements in Spine Surgery for Pediatric Cancer Patients

Children's Cancer Hospital Egypt 57357

Phase 3 Unknown
38 enrolled
CNS

Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡